Advertisement
Screener

NUWELLIS, INC. (NUWE) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

1.7 / 5 stars · 32/93 Roast Me

NUWELLIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

NUWELLIS, INC. (NUWE) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 0.92% for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2016-11-14

  • NUWELLIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2013-03-31 was 1.30%, a 5.80% decline year-over-year.
  • NUWELLIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2012-03-31 was 1.38%.
  • NUWELLIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2012 was 1.52%, a 6.29% increase from fiscal 2011.
  • NUWELLIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2011 was 1.43%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest RateShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month
2016-09-300.92%
10-Q · filed 2016-11-14
2016-07-200.94%
10-Q · filed 2016-11-14
2013-03-311.30%
10-Q · filed 2013-05-14
2012-12-311.52%
10-K · filed 2013-03-12
2012-03-311.38%
10-Q · filed 2013-05-14
2011-12-311.43%
10-K · filed 2013-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENDRA Life Sciences Inc. (NDRA)United States$0.009B
IRIDEX CORP (IRIX)United States$0.011B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B